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Abstract: Radiotherapy is one of the main methods in the successful treatment of cancer. The tumor is
irradiated with photons or charged particles (e.g. protons), and in the case of massive charged particles,
the treatment results in less unnecessary dose outside the tumor and therefore less side effects for the
patient and a faster recovery. However, the dose planning of hadron therapy is calculated from photon
CT measurements, which results in large uncertainties in the planning and therefore in a necessary
enlargement of the treatment area. This uncertainty can be reduced by performing the CT scan using
protons. The current contribution shows the development of a sampling calorimeter for proton CT
measurements and describes the state of the project.
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1. Introduction
As shown in Ref. [1], around 40% of the population is effected by cancer at a certain point in their
life. Radiotherapy is one of the main successful methods in treating cancer [2]. In radiotherapy, photons
or hadrons can be used to irradiate the patient. The goal of these treatments is to damage the DNA of
the cancer cells, while causing as little damage as possible to the healthy tissues. This damage can be
minimized by irradiating the patient from several angles, therefore delocalizing it. If it is possible to
focus the radiation on the tumor, the damage can be further minimized. If photons are used, only the
delocalization can be applied as photons are absorbed mostly at their entrance to the patient (see Figure 1).
However, if protons or other charged particles are used, the damage can be focused inside the tumor by
adjusting the energy of the beam and positioning the Bragg peak in the tumor.
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Figure 1. Relative dose of photons and protons as a function of the depth in the tissue [3].
2. Computer tomography with protons
The problem of current hadron therapy treatments is that the treatment is planned after acquiring
an image of the patient by a photon CT scan. This results in large uncertainties (around 3–4%) in the
determination of the stopping power of protons in front of the tumor [4]. This is due to the fact that the
relation of the attenuation coefficients of photons and the stopping power of protons is not linear and not
one-to-one as it differs depending on the type of the tissue [5].
This problem can be solved by using protons for the imaging in the CT measurement instead of
photons, therefore the measurement will give directly the stopping power for protons. This would reduce
the uncertainty by more than a magnitude to 0.3% [4]. Such a measurement would use protons with a
higher energy than the ones used for the treatment, such that their Bragg peak would fall outside of the
patient and in the detector placed behind the patient. The position of the protons has to be determined
before entering the patient and after leaving the patient, and after the patient the energy of the protons
has to be measured as well. Before the patient, the position of the protons can be determined by the
measurement of the beam position or by a tracking detector with very low material budget (maximum
50–100 µm of silicon). After the patient the position and the energy measurement can be achieved by
a high resolution sampling calorimeter. The concept of such a detector can be seen in Figure 2. If the
measurement is done prior to the treatment, it can be used for the planning of the treatment, while if it is
done quasi-simultaneously, it can be used for dose verification, dose optimization or patient alignment.
Patient alignment is not a trivial task, as the unavoidable movement of the patient has to be taken into
account during the treatment. This can be done by monitoring the patient with a quasi-simultaneous
proton CT measurement.
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Figure 2. The concept of a proton CT detector.
3. The proposed calorimeter
The active part of the sampling calorimeter will be the ALPIDE sensor [6] which was originally
developed for the Inner Tracking System of the ALICE detector [7]. These ALPIDE layers will alternate
with aluminum layers which act as energy degraders for the protons. There will be 41 sensitive layers and
41 degrader layers and each aluminum layer will be 3.5 mm thick. The full front area of the detector will
be 27 cm × 15 cm, which is made up of 9 × 9 ALPIDE sensors. The proposed calorimeter design can be
seen in Figure 3.
Figure 3. The proposed design of the sampling calorimeter. The red layers are the sensitive layers which
alternate with the gray aluminum layers. The blue sphere represents the patient.
The ALPIDE is a digital MAPS type silicon detector. It was designed to function in the ALICE detector,
therefore it is radiation tolerant up to 1.7× 1013 1 MeV neq/cm2 non-ionizing dose and up to 2700 krad
ionizing radiation. This is important as in the case of the proton CT, the detector will be placed directly in
the beam. The ALPIDE has a high detection efficiency (> 99%), good spatial resolution (∼ 5 µm) and low
noise (< 10−6 hits/event/pixel) [6]. It can be produced in a 50 µm and a 100 µm thick version, therefore, if
needed, it can be used in the tracker in front of the patient as well.
4. Results from the prototype
The first prototype of the calorimeter was not optimized for detecting protons, but for measuring
electromagnetic showers. This prototype used MIMOSA23 sensors [8] and used 3.3 mm tungsten absorbers
instead of aluminum as a degrader [9]. It was tested in a proton beam at KVI – Center for Advanced
Radiation Technology in Groningen [10]. The comparison of the results with simulations can be seen in
Figure 4 which shows the number of reconstructed protons as a function of their reconstructed range. In
both cases the Bragg peak is clearly visible around 230 mm, and the simulation (left panel) describes the
test beam data (right panel) well. In Figure 5, the reconstructed range of the tracks is shown as a function
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of the energy of the beam. The agreement between data and simulation is good here as well, and the
observed linear trend shows that the range is a good measurement of the energy of the incoming protons.
Figure 4. Comparison of the simulations (left panel) and the measured results (right panel) of the
prototype [11].
Figure 5. Reconstructed range of the protons as a function of the energy of the beam [11].
5. Conclusions
In conclusion, with the help a proton CT the dose estimation of hadron therapy will become more
accurate, therefore it will have less side effects and can be applied closer to critical organs. As a proton
CT detector a sampling calorimeter of alternating ALPIDE and aluminum layers is proposed. The first
prototype of such a detector, which was optimized for electromagnetic showers instead of the energy
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measurement of protons, shows a good performance, and its performance can be well described by Monte
Carlo simulations.
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Abbreviations
The following abbreviations are used in this manuscript:
ALICE A Large Ion Collider Experiment
ALPIDE ALICE PIxel DEtector
CT Computer Tomography
DNA DeoxyriboNucleic Acid
MAPS Monolithic Active Pixel Sensor
pCT proton Computer Tomography
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